ALUX Co., Ltd. (KOSDAQ:475580)
11,210
+20 (0.18%)
At close: Aug 7, 2025, 3:30 PM KST
Ligand Pharmaceuticals Revenue
ALUX Co., Ltd. had revenue of 31.19B KRW in the half year ending December 31, 2024. This brings the company's revenue in the last twelve months to 56.74B, up 9.45% year-over-year. In the year 2024, ALUX Co., Ltd. had annual revenue of 55.04B with 0.36% growth.
Revenue (ttm)
56.74B
Revenue Growth
+9.45%
P/S Ratio
2.73
Revenue / Employee
525.38M
Employees
108
Market Cap
154.94B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 55.04B | 196.61M | 0.36% |
Dec 31, 2023 | 54.85B | 17.68B | 47.58% |
Dec 31, 2022 | 37.16B | 11.13B | 42.76% |
Dec 31, 2021 | 26.03B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition